Building 'validated' mouse models of human cancer

Current Opinion in Cell Biology

Volumn 13, Issue 6, 2001, Pages 778-784

  Hann, B ^a   Balmain, A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CANCER; CANCER GENETICS; CANCER MODEL; CANCER RESEARCH; CANCER THERAPY; CARCINOGENESIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR; TUMOR GROWTH;

ANIMALIA; MURINAE;

EID: 0035545961     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(00)00283-0     Document Type: Review

References (68)

1. Studying cancer in the mouse
2. Insights into cancer from transgenic mouse models
3. Mouse models for sporadic cancer
4. The laboratory mouse in cancer research
5. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
6. Roles for Nkx3.1 in prostate development and cancer
7. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes
8. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
9. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice
10. Gliomagenesis: Genetic alterations and mouse models
11. Pten is essential for embryonic development and tumour suppression
12. Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency
13. The murine gene p27Kip1 is haplo-insufficient for tumour suppression
14. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
15. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
16. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis
17. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
18. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
19. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction
20. Regulation of cutaneous malignancy by (gamma-delta) T cells
21. Ink4a with retention of p19Arf predisposes mice to tumorigenesis
22. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
23. Multicolour spectral karyotyping of mouse chromosomes
24. Dual inactivation of RB and p53 pathways in RAS-induced melanomas
25. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
26. KIP1 cooperate in prostate cancer tumor suppression in the mouse
27. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis
28. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
29. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
30. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer
31. Mouse tumor model for neurofibromatosis type 1
32. NF1 tumor suppressor gene function: Narrowing the GAP
33. Specific association of human telomerase activity with immortal cells and cancer
34. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
35. Longevity, stress response, and cancer in aging telomerase-deficient mice
36. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
37. Pathologic progression of autochthonous prostate cancer in the TRAMP model
38. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain- specific effects
39. Cancer resistance genes in mice: Models for the study of tumour modifiers
40. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor
41. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype
42. Neonatal sunburn and melanoma in mice
43. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice
44. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice
45. Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis
46. Less is more, regularly: Metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice
47. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins
48. Essential role for oncogenic Ras in tumour maintenance
49. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion
50. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse
51. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
52. Cre recombinase: The universal reagent for genome tailoring
53. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays
54. Carcinogenesis in mouse and human cells: Parallels and paradoxes
55. The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted
56. Prostate cancer in a transgenic mouse
57. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
58. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
59. A mouse model of human familial adenomatous polyposis
60. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors
61. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes
62. Colorectal carcinomas in mice lacking the catalytic subunit of PIKγ
63. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease
64. Mouse models for breast cancer
65. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR α under control of cathepsin G regulatory sequences
66. Acute leukemia with promyelocytic features in PML/RARα transgenic mice
67. A bcr-3 isoform of RARα-PML potentiates the development of PML- RARαα-driven acute promyelocytic leukemia
68. Leukemia initiated by PMLRARα: The PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable